ProCE Banner Activity

Interpreting the Nuances of DOAC Therapies for Patients With NVAF: The Pharmacist’s Role

Clinical Thought

Cardiology pharmacists’ perspectives on the pharmacist’s role in screening for NVAF, access to DOAC therapies, and dosing nuances.

Released: April 13, 2022

Expiration: April 12, 2023

Share

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance.

Bristol Myers Squibb

Pfizer Alliance

Faculty Disclosure

Kathleen A. Lusk, PharmD, BCPS, BCCP, has no relevant conflicts of interest to report.